Neutrophil:lymphocyte ratio is positively related to type 2 diabetes in a large-scale adult population: a Tianjin Chronic Low-Grade Systemic Inflammation and Health cohort study.

AIM It is widely known that inflammation is related to type 2 diabetes (T2D), but few studies have shown a direct relationship between the immune system and T2D using a reliable biomarker. Neutrophil:lymphocyte ratio (NLR) is an easy-to-analyze inflammation biomarker, but few studies have assessed the relationship between NLR and T2D. In order to evaluate how NLR is related to T2D, we designed a large-scale cross-sectional and prospective cohort study in an adult population. SUBJECTS AND METHODS Participants were recruited from the Tianjin Medical University General Hospital-Health Management Centre. Both a baseline cross-sectional (n=87,686) and a prospective (n=38,074) assessment were performed. Participants without a history of T2D were followed up for ∼ 6 years (with a median follow-up of 2.7 years). Adjusted logistic and Cox proportional hazards regression models were used to assess relationships between the quintiles of NLR and T2D (covariates: age, sex, BMI, smoking status, drinking status, hypertension, hyperlipidemia, and family history of cardiovascular disease, hypertension, hyperlipidemia, or diabetes). RESULTS The prevalence and incidence of T2D were 4.9% and 6.8/1000 person-years respectively. The adjusted odds ratio and hazard ratio (95% CI) of the highest NLR quintile were 1.34 (1.21, 1.49) and 1.39 (1.09, 1.78) (both P for trend <0.01) respectively as compared to the lowest quintile of NLR. Leukocyte, neutrophil, and lymphocyte counts do not significantly predict the eventual development of T2D. CONCLUSION The present study demonstrates that NLR is related to the prevalence and incidence of T2D, and it suggests that NLR may be an efficient and accurate prognostic biomarker for T2D.

[1]  Hiroshi Yamamoto,et al.  RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication , 2013, Front. Endocrinol..

[2]  T. Yamakawa,et al.  T lymphopaenia in relation to body mass index and TNF‐α in human obesity: adequate weight reduction can be corrective , 2001, Clinical endocrinology.

[3]  G. Meng,et al.  Soft drink consumption is associated with depressive symptoms among adults in China. , 2015, Journal of affective disorders.

[4]  R. Farah,et al.  Association of Neutrophil to Lymphocyte Ratio With Presence and Severity of Gastritis Due to Helicobacter pylori Infection , 2014, Journal of clinical laboratory analysis.

[5]  S. Manuck,et al.  Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. , 2010, Metabolism: clinical and experimental.

[6]  Heejung Bang,et al.  Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. , 2005, Diabetes care.

[7]  S. Haffner,et al.  Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.

[8]  S. Inan,et al.  Neutrophil-to-lymphocyte ratio as a quick and reliable predictive marker to diagnose the severity of diabetic retinopathy. , 2013, Diabetes technology & therapeutics.

[9]  T. Costantino,et al.  Neutrophil to lymphocyte ratio and cardiovascular diseases: a€review , 2012 .

[10]  P. Wahl,et al.  Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. , 2000, American journal of epidemiology.

[11]  C. Pollock,et al.  Role of Toll-like receptors in diabetic nephropathy. , 2014, Clinical science.

[12]  W. Lu,et al.  Increasing Prevalence of Type 2 Diabetes in Chinese Adults in Shanghai , 2012, Diabetes Care.

[13]  J. Olefsky,et al.  Neutrophils mediate insulin resistance in high fat diet fed mice via secreted elastase , 2012, Nature Medicine.

[14]  S. Legrand-Poels,et al.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. , 2014, Diabetes research and clinical practice.

[15]  A. Avcı,et al.  The Relationship between Neutrophil/Lymphocyte Ratio and Calcific Aortic Stenosis , 2014, Echocardiography.

[16]  Qing Li,et al.  The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy. , 2014, Human immunology.

[17]  B. Zinman,et al.  White blood cell subtypes, insulin resistance and β‐cell dysfunction in high‐risk individuals – the PROMISE cohort , 2014, Clinical endocrinology.

[18]  Z. Öztürk,et al.  Is there a link between neutrophil-lymphocyte ratio and microvascular complications in geriatric diabetic patients? , 2013, Journal of Endocrinological Investigation.

[19]  Gerardo Heiss,et al.  Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study , 1999, The Lancet.

[20]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[21]  J. Murabito,et al.  Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. , 2008, Journal of the American College of Cardiology.

[22]  S. El-Sayegh,et al.  Neutrophil-to-Lymphocyte Ratio as a Predictor of Worsening Renal Function in Diabetic Patients (3-Year Follow-Up Study) , 2012, Renal failure.

[23]  P. Halban,et al.  Cytokine production by islets in health and diabetes: cellular origin, regulation and function , 2010, Trends in Endocrinology & Metabolism.

[24]  Joachim Spranger,et al.  Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.

[25]  M. Hanefeld,et al.  Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance. , 2002, Diabetologia.

[26]  M. V. Vander Weg,et al.  Prevalence of alternative forms of tobacco use in a population of young adult military recruits. , 2008, Addictive behaviors.

[27]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[28]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[29]  M. Taskinen,et al.  Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. , 2003, Atherosclerosis.

[30]  S. Haffner,et al.  Differential white cell count and incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study , 2013, Diabetologia.

[31]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[32]  S. Haffner,et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.

[33]  A. Vinik,et al.  Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease , 2013, Journal of diabetes investigation.

[34]  W. Aronow,et al.  Mortality, Left Ventricular Ejection Fraction, and Prevalence of New Left Ventricular Wall Motion Abnormality at Long-term Follow-up in Patients With Implantable Cardioverter Defibrillators Treated With Biventricular Pacing Versus Right Ventricular Pacing , 2007, American journal of therapeutics.

[35]  W. Rathmann,et al.  Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-α or its receptors , 2002, Diabetologia.

[36]  Qing Zhang,et al.  Serum Immunoglobulin M Concentration Is Positively Related to Metabolic Syndrome in an Adult Population: Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) Cohort Study , 2014, PloS one.

[37]  P. Scherer,et al.  Keystone meeting summary: 'Adipogenesis, obesity, and inflammation' and 'Diabetes mellitus and the control of cellular energy metabolism, ' January 21-26, 2006, Vancouver, Canada. , 2006, Genes & development.

[38]  K. Dou,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[39]  C. Stehouwer,et al.  Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. , 2002, Atherosclerosis.

[40]  K. Suzuki,et al.  White blood-cell count and the risk of impaired fasting glucose or Type II diabetes in middle-aged Japanese men , 2002, Diabetologia.

[41]  E. Feldman,et al.  Diabetic neuropathy: mechanisms to management. , 2008, Pharmacology & therapeutics.